PI3K/Akt/mTOR (mammalian target of rapamycin) signaling pathway is involved in the constitutive activation of BCR signaling and cell adhesion-mediated drug resistance within tumor microenvironment [107]. This evidence concerns the gene MTOR and neoplasm.